Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Mol Carcinog

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    May 2018
  1. LI Z, Fan J, Li N, Zhu M, et al
    Fine mapping in TERT-CLPTM1L region identified three independent lung cancer susceptibility signals: a large-scale multi-ethnic population study.
    Mol Carcinog. 2018 May 29. doi: 10.1002/mc.22843.
    PubMed     Text format     Abstract available


    March 2018
  2. YANG Y, Sun Y, Wu Y, Tang D, et al
    Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer.
    Mol Carcinog. 2018 Mar 22. doi: 10.1002/mc.22805.
    PubMed     Text format     Abstract available


    January 2018
  3. SU YC, Chang H, Sun SJ, Liao C, et al
    Differential Impact of CX3CL1 on Lung Cancer Prognosis in Smokers and Non-smokers.
    Mol Carcinog. 2018 Jan 30. doi: 10.1002/mc.22787.
    PubMed     Text format     Abstract available


    December 2017
  4. WANG H, Wang L, Cao L, Zhang Q, et al
    Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Mol Carcinog. 2017 Dec 26. doi: 10.1002/mc.22777.
    PubMed     Text format     Abstract available


    November 2017
  5. YANG L, Lin Z, Wang Y, Gao S, et al
    MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
    Mol Carcinog. 2017 Nov 16. doi: 10.1002/mc.22765.
    PubMed     Text format     Abstract available


    October 2017
  6. FENG Y, Wang Y, Liu H, Liu Z, et al
    Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.
    Mol Carcinog. 2017 Oct 26. doi: 10.1002/mc.22748.
    PubMed     Text format     Abstract available


  7. PAN Z, Liu L, Nie W, Miggin S, et al
    Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.
    Mol Carcinog. 2017 Oct 25. doi: 10.1002/mc.22756.
    PubMed     Text format     Abstract available


  8. TAO S, de la Vega MR, Chapman E, Ooi A, et al
    The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer.
    Mol Carcinog. 2017 Oct 4. doi: 10.1002/mc.22745.
    PubMed     Text format     Abstract available


    September 2017
  9. LI Y, Zhang H, Li Y, Zhao C, et al
    MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Mol Carcinog. 2017 Sep 21. doi: 10.1002/mc.22741.
    PubMed     Text format     Abstract available


  10. HAN Y, Tang Z, Zhao Y, Li Q, et al
    TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Mol Carcinog. 2017 Sep 19. doi: 10.1002/mc.22740.
    PubMed     Text format     Abstract available


  11. ZHAO H, Zhang D, Yang L, Wang E, et al
    p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
    Mol Carcinog. 2017 Sep 12. doi: 10.1002/mc.22734.
    PubMed     Text format     Abstract available


    July 2017
  12. ZHANG X, Cai L, Zhou H, Liu Y, et al
    Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22700.
    PubMed     Text format     Abstract available


  13. YOU BR, Park WH
    Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22701.
    PubMed     Text format     Abstract available


    May 2017
  14. ZHU X, Li D, Zhang Z, Zhu W, et al
    Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.
    Mol Carcinog. 2017;56:1449-1460.
    PubMed     Text format     Abstract available


    April 2017
  15. ERDEM JS, Arnoldussen YJ, Skaug V, Haugen A, et al
    Copy number variation, increased gene expression and molecular mechanisms of Neurofascin in lung cancer.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22664.
    PubMed     Text format     Abstract available


  16. ZHOU C, Chen T, Xie Z, Qin Y, et al
    RACK1 Forms a Complex with FGFR1 and PKM2 and Stimulates the Growth and Migration of Squamous Lung Cancer Cells.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22663.
    PubMed     Text format     Abstract available


  17. XIE M, Wu X, Zhang J, Zhang J, et al
    Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22661.
    PubMed     Text format     Abstract available


  18. ZHANG X, Zhou H, Cai L, Fan C, et al
    Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22660.
    PubMed     Text format     Abstract available


    March 2017
  19. CHAE DK, Ban E, Yoo YS, Kim EE, et al
    MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Mol Carcinog. 2017 Mar 31. doi: 10.1002/mc.22655.
    PubMed     Text format     Abstract available


    February 2017
  20. FENG C, Xia Y, Zou P, Shen M, et al
    Curcumin analogue L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.
    Mol Carcinog. 2017 Feb 20. doi: 10.1002/mc.22633.
    PubMed     Text format     Abstract available


  21. YIN J, Liu H, Liu Z, Owzar K, et al
    Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus.
    Mol Carcinog. 2017 Feb 2. doi: 10.1002/mc.22622.
    PubMed     Text format     Abstract available


    December 2016
  22. MAN S, Li J, Qiu P, Liu J, et al
    Inhibition of lung cancer in diethylnitrosamine-induced mice by Rhizoma paridis saponins.
    Mol Carcinog. 2016 Dec 19. doi: 10.1002/mc.22601.
    PubMed     Text format     Abstract available


    November 2016
  23. ZHOU F, Wang Y, Liu H, Ready N, et al
    Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk - a re-analysis of eight GWASs.
    Mol Carcinog. 2016 Nov 2. doi: 10.1002/mc.22585.
    PubMed     Text format     Abstract available


    September 2016
  24. LI J, Lu J, He Y, Wu Y, et al
    A new functional IDH2 genetic variant is associated with the risk of lung cancer.
    Mol Carcinog. 2016 Sep 20. doi: 10.1002/mc.22573.
    PubMed     Text format     Abstract available


  25. BASSI DE, Zhang J, Renner C, Klein-Szanto AJ, et al
    Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
    Mol Carcinog. 2016 Sep 1. doi: 10.1002/mc.22550.
    PubMed     Text format     Abstract available


    August 2016
  26. ZHANG M, Zeng J, Zhao Z, Liu Z, et al
    Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
    Mol Carcinog. 2016 Aug 8. doi: 10.1002/mc.22536.
    PubMed     Text format     Abstract available


    May 2016
  27. GAO W, Jin J, Yin J, Land S, et al
    KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients.
    Mol Carcinog. 2016 May 16. doi: 10.1002/mc.22501.
    PubMed     Text format     Abstract available


    January 2016
  28. SHI L, Zhang B, Sun X, Zhang X, et al
    CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
    Mol Carcinog. 2016 Jan 12. doi: 10.1002/mc.22450.
    PubMed     Text format     Abstract available


  29. WEI L, Yao Y, Zhao K, Huang Y, et al
    Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3beta signaling in snail-expressing non-small-cell lung cancer cells.
    Mol Carcinog. 2016 Jan 6. doi: 10.1002/mc.22456.
    PubMed     Text format     Abstract available


  30. RAVI J, Elbaz M, Wani NA, Nasser MW, et al
    Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.
    Mol Carcinog. 2016 Jan 6. doi: 10.1002/mc.22451.
    PubMed     Text format     Abstract available


    December 2015
  31. SU J, Wu S, Wu H, Li L, et al
    CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/beta-catenin-FoxM1-Twist signaling.
    Mol Carcinog. 2015 Dec 1. doi: 10.1002/mc.22443.
    PubMed     Text format     Abstract available


  32. OJI Y, Tatsumi N, Kobayashi J, Fukuda M, et al
    Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
    Mol Carcinog. 2015;54:1758-71.
    PubMed     Text format     Abstract available


  33. CHOWDHURY SR, Sengupta S, Biswas S, Sen R, et al
    Low fucose containing bacterial polysaccharide facilitate mitochondria-dependent ROS-induced apoptosis of human lung epithelial carcinoma via controlled regulation of MAPKs-mediated Nrf2/Keap1 homeostasis signaling.
    Mol Carcinog. 2015;54:1636-55.
    PubMed     Text format     Abstract available


    November 2015
  34. YU SL, Lee DC, Sohn HA, Lee SY, et al
    Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
    Mol Carcinog. 2015 Nov 20. doi: 10.1002/mc.22439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: